Influence of age upon Ifosfamide-induced nephrotoxicity

Pediatr Blood Cancer. 2004 May;42(5):427-32. doi: 10.1002/pbc.20011.

Abstract

Background: Ifosfamide-induced nephrotoxicity is well recognized in children, although it has also been reported in adults. Whether ifosfamide nephrotoxicity is more common in children than in adults is not known.

Procedure: Medical records of adults and children diagnosed with sarcoma whom received ifosfamide with a cumulative dose >20 g/m(2) were evaluated. Twenty-five children (</=18-years of age) and 28 adults were identified.

Results: National Cancer Institute Common Toxicity Criteria grade 3-4 ifosfamide-induced nephrotoxicity was present in 24 and 17% of children and adults, respectively (P = 0.58). Cumulative ifosfamide doses were similar between the two populations, with the median (range) of 70.2 g/m(2) (22.4-72) for children and 59 g/m(2) (20.8-146) for adults (P = 0.25). Logistic regression analysis indicated that neither age or cumulative ifosfamide dose were associated with grade 3-4 ifosfamide-induced nephrotoxicity (P = 0.36).

Conclusions: Children and adults receiving >20 g/m(2) of ifosfamide have similar susceptibility to ifosfamide-induced nephrotoxicity. Factors other than age and cumulative dose should be considered for understanding the inter-individual variation in nephrotoxicity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Antineoplastic Agents, Alkylating / toxicity*
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Drug Evaluation
  • Female
  • Humans
  • Ifosfamide / therapeutic use
  • Ifosfamide / toxicity*
  • Infant
  • Male
  • Middle Aged
  • Nephrosis / chemically induced*
  • Regression Analysis
  • Retrospective Studies
  • Risk Factors
  • Sarcoma / complications
  • Sarcoma / drug therapy

Substances

  • Antineoplastic Agents, Alkylating
  • Ifosfamide